Walking Through a Redesign That Made Clinical Trial Software Easier to Use

Walk me through a project in which you simplified the user interface of software used to run clinical trials. What made it hard to use, what did you change, and how did you know it worked? ```hint Find where the complexity comes from Before describing the screens you changed, pin down which users struggled, at which step of the trial workflow, and which parts of the complexity were required by regulation or the protocol rather than created by the product. ``` ### Clarifying Questions - Which users should the story center on: site coordinators entering data, monitors reviewing it, sponsor study teams, or patients using an electronic diary? - If my experience is not with clinical trial software itself, may I use a redesign of another regulated, form-heavy healthcare tool? - Was the brief a redesign of the whole product, or the simplification of one high-friction workflow such as data entry or resolving data queries? ### What a Strong Answer Covers - A precise picture of the users, the workflow step, and the evidence (observation, support data, error or query rates) showing where complexity hurt - Separating complexity mandated by regulation and trial protocols, such as audit trails and electronic signatures, from complexity the product had added - The concrete design changes, the alternatives considered, and how compliance and data quality were protected - How the redesign was validated with users and rolled out in a validated system without disrupting live studies - Measured outcomes for users and for trial operations, and what the candidate would do differently ### Follow-up Questions - How did you handle a quality, regulatory or sponsor stakeholder who insisted that a field or step had to stay? - Experienced site staff had memorized the old interface. How did you handle studies that were already running? - Which metric would have told you the redesign made data quality worse, and did you track it?